STAY INFORMED. VISIT NHIA.ORG/COVID19 FOR INFORMATION AND RESOURCES ABOUT CORONAVIRUS DISEASE (COVID-19).
Be part of NHIF’s benchmarking program to collect industry-wide, standardized data to establish a national reference point for performance and clinical metrics.
NHIA’s Clinical Program Manager Michelle Simpson, PharmD, BCSCP, MWC presented research conducted by the National Home Infusion Foundation (NHIF) at ID Week, the meeting of the Infectious Diseases Society of America (IDSA) held October 19-23 in Washington, D.C.
A diverse group of 30 patient and stakeholder groups are calling on Congress to address Medicare beneficiary access to home infusion services. In a letter to lawmakers, which brings together stakeholders from across the care continuum, the groups urge congressional leaders to advance the Preserving Patient Access to Home Infusion Act (S. 2652/H.R. 5067) and increase access to home infusion therapy for Medicare beneficiaries.
Registration is now open for the National Home Infusion Association’s 2023 Annual Conference (NHIA 2023), to be held March 25-29, 2023, at the Gaylord National Resort & Convention Center in Washington, D.C.
The National Home Infusion Association (NHIA) was honored as a “COVID Hero of New York” by NewYorkBIO, a group that brings together nearly 300 of the state’s bioscience companies, universities, research institutions, and others dedicated to advancing life science research and commercialization.
NHIA submitted comments pointing out the advantages of home-based administration of subcutaneous Ig (SCIG) for chronic inflammatory demyelinating polyneuropathy (CIPD).
Support NHIF and Infuse Wellness this October into your life and others. There are many ways to participate—get together with your colleagues and form a team to compete against the NHIA staff and other members.
NHIA committees bring together thought leaders and innovators to complement and support staff efforts to promote and achieve the association’s mission.
NHIA submitted comments on a CMS proposed rule (CMS-1770-P) that would affect Medicare payments and coverage of COVID-19 vaccines and monoclonal antibodies (mAbs) and coding and billing requirements related to the use of single dose containers and drug waste.
© 2022, National Home Infusion Association
All Rights Reserved by NHIA
